Literature DB >> 19214492

Influence of obstetric complication severity on brain morphology in schizophrenia: an MR study.

G Bersani1, A Quartini, G Manuali, A Iannitelli, D Pucci, F Conforti, C Di Biasi, G Gualdi.   

Abstract

INTRODUCTION: The purpose of this study was to determine if a causal relationship exists between obstetric complications (OCs) severity and linear magnetic resonance (MR) measurements of brain atrophy in patients with schizophrenia.
MATERIALS AND METHODS: Linear measurements of ventricular enlargement (bifrontal span, Evans ratio, and bicaudate ratio) and hippocampal atrophy (interuncal distance) were completed on MR images obtained in 47 patients with schizophrenia. Regression analysis was used to look at association with OCs severity, assessed by the "Midwife protocol" of Parnas and colleagues. The relationship between MR measurements and phenomenologic variables such as age at onset, illness duration, and exposure to antipsychotic medications was explored. The relationship between MR measurements, OCs severity, and symptom presentation was also investigated.
RESULTS: OCs severity was significantly associated with MR measurements of ventricular enlargement (bifrontal span, Evans ratio). As the severity of OCs increased, bifrontal span and Evans ratio increased. This effect was independent of age at onset, illness duration, or even antipsychotic treatment. Interestingly, bifrontal span, Evans ratio, and OCs severity score all showed a significant positive correlation with hallucinatory symptomatology.
CONCLUSION: Although confirmatory studies are needed, our findings would support the idea that environmental factors, in this case severe OCs, might partly contribute to ventricular abnormalities in schizophrenia.

Entities:  

Mesh:

Year:  2009        PMID: 19214492     DOI: 10.1007/s00234-009-0501-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  39 in total

1.  Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.

Authors:  Paola Dazzan; Kevin D Morgan; Ken Orr; Gerard Hutchinson; Xavier Chitnis; John Suckling; Paul Fearon; Philip K McGuire; Rosemarie M Mallett; Peter B Jones; Julian Leff; Robin M Murray
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

2.  Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls.

Authors:  T D Cannon; T G van Erp; M Huttunen; J Lönnqvist; O Salonen; L Valanne; V P Poutanen; C G Standertskjöld-Nordenstam; R E Gur; M Yan
Journal:  Arch Gen Psychiatry       Date:  1998-12

3.  Radial width of the temporal horn: a sensitive measure in Alzheimer disease.

Authors:  Giovanni B Frisoni; Cristina Geroldi; Alberto Beltramello; Angelo Bianchetti; Giuliano Binetti; Giovanni Bordiga; Charles DeCarli; Mikko P Laakso; Hilkka Soininen; Cristina Testa; Orazio Zanetti; Marco Trabucchi
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

4.  Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study.

Authors:  C Dalman; H V Thomas; A S David; J Gentz; G Lewis; P Allebeck
Journal:  Br J Psychiatry       Date:  2001-11       Impact factor: 9.319

5.  Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study.

Authors:  Colm McDonald; Ed Bullmore; Pak Sham; Xavier Chitnis; John Suckling; James MacCabe; Muriel Walshe; Robin M Murray
Journal:  Br J Psychiatry       Date:  2005-05       Impact factor: 9.319

6.  The role of the striatum in rule application: the model of Huntington's disease at early stage.

Authors:  Marc Teichmann; Emmanuel Dupoux; Sid Kouider; Pierre Brugières; Marie-Françoise Boissé; Sophie Baudic; Pierre Cesaro; Marc Peschanski; Anne-Catherine Bachoud-Lévi
Journal:  Brain       Date:  2005-03-23       Impact factor: 13.501

7.  Bicaudate index on magnetic resonance imaging: effects of normal aging.

Authors:  P M Doraiswamy; L Patterson; C Na; M M Husain; O Boyko; W M McDonald; K R Krishnan
Journal:  J Geriatr Psychiatry Neurol       Date:  1994 Jan-Mar       Impact factor: 2.680

8.  Perinatal complications and clinical outcome within the schizophrenia spectrum.

Authors:  J Parnas; F Schulsinger; T W Teasdale; H Schulsinger; P M Feldman; S A Mednick
Journal:  Br J Psychiatry       Date:  1982-04       Impact factor: 9.319

9.  Obstetric complications in schizophrenia and the validity of maternal recall.

Authors:  E O'Callaghan; C Larkin; J L Waddington
Journal:  Psychol Med       Date:  1990-02       Impact factor: 7.723

10.  Schizophrenia syndromes associated with changes in ventricle-to-brain ratios: a serial high-resolution three-dimensional magnetic resonance imaging study in first-episode schizophrenia patients using subvoxel registration and semiautomated quantification.

Authors:  B K Puri; N Saeed; A J Richardson; A Oatridge; J V Hajnal; G M Bydder
Journal:  Int J Clin Pract       Date:  2005-04       Impact factor: 2.503

View more
  4 in total

Review 1.  Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions.

Authors:  Cindy H Liu; Matcheri S Keshavan; Ed Tronick; Larry J Seidman
Journal:  Schizophr Bull       Date:  2015-04-22       Impact factor: 9.306

2.  An MRI study of age-related changes in the dimensions related temporal lobe.

Authors:  Ismail Salk; Mehmet Haydar Atalar; Ferhat Sezer; Hulusi Egilmez; Ali Cetin; Mubeccel Arslan
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 3.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

Review 4.  Neuroprotection in Schizophrenia and Its Therapeutic Implications.

Authors:  Yong-Ku Kim; Kyoung-Sae Na
Journal:  Psychiatry Investig       Date:  2017-07-11       Impact factor: 2.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.